Cutaneous α-Synuclein and Age Spots in Neurodegeneration: A Systematic Review and Testable Hypothesis.
Cutaneous α-Synuclein and Age Spots in Neurodegeneration: A Systematic Review and Testable Hypothesis.
Where did the research take place?
The study site has not been established. Author addresses may differ from where the research occurred.
Rome, IT · Author affiliation
Life and Health Science Department, Link University, 00165 Rome, Italy.Location evidence
Viterbo, IT · Author affiliation
Otolaryngology Department Santa Rosa Hospital, 01100 Viterbo, Italy.Location evidence
Foggia, IT · Author affiliation
Dermatology Department, University of Foggia, 71122 Foggia, Italy.Location evidence
Cambridge, US · Author affiliation
Highland Instruments, Inc., Cambridge, MA 02238, USA.Location evidence
A plain-language reading has not been prepared for this paper yet.
Original abstract
Recent studies have identified phosphorylated α-synuclein in the skin of individuals with neurodegenerative disease. The levels of this protein in the skin have been correlated with disease severity. This protein has been specifically studied in alpha-synucleinopathies such as Parkinsons' Disease (PD) and Multiple System Atrophy (MSA). Given that skin biopsy studies have often shown high levels of phosphorylated α-synuclein in the neck area, and that other clinical studies have described easily identifiable changes in facial skin features, this systematic review explores whether age spots, which are very common in sun-exposed areas (hands and face), could serve as early indicators of neurodegenerative disease. We performed a systematic review of the literature in three databases (Google, Scopus and Pubmed) following PRISMA guidelines. We used the following keywords: "alpha-synuclein and skin", "alpha-synuclein and skin spots", "alpha-synuclein and solar lentigo", "alpha-synuclein and age spots", "alpha-synuclein and melanocytes", "skin biopsy and synucleinopathies", "skin biopsy and neurodegenerative disease", and "Parkinson's Disease. Eleven studies were identified and included. Based on the study results and preliminary evidence in the literature evaluating the effect of α-synuclein on keratinocytes and melanocytes, we propose that the accumulation of this protein within the skin may produce visible alterations that can be quantified to enable early, noninvasive detection of neurodegenerative disease.